Navigation Links
Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy

Cytos Biotechnology reports positive results from placebo controlled phase IIa study in patients suffering from house dust mite allergy

SCHLIEREN (Zurich), Switzerland, May 15, 2007 - Cytos Biotechnology AG (SWX:CYTN) reported today positive results from a multi-centre and placebo-controlled phase IIa study with different formulations of CYT003-QbG10, an immunotherapeutic product candidate for the treatment of allergic diseases. The study included 40 patients suffering from mild to moderate allergic rhinitis due to house dust mite allergy and assessed in a double-blind setting the safety, tolerability and exploratory efficacy of CYT003-QbG10 monotherapy, CYT003-QbG10 combined with a low dose of house dust mite allergen extract (designated CYT005-AllQbG10), allergen extract alone and placebo. Exploratory efficacy was determined by evaluating the allergic disease status of the patients before and after treatment by the conjunctival provocation test.

Both formulations of CYT003-QbG10 tested were safe and well tolerated. The table below summarizes
on the first results obtained two weeks after the last dose. A statistically significant increase in the
median allergen tolerance against baseline was observed only in the two treatment arms which
comprised QbG10 (i.e. CYT003-QbG10 monotherapy and CYT005-AllQbG10), whereas none of the
intergroup comparisons achieved statistical significance.

CYT003-QbG10
n=10
CYT005-AllQbG10
n=10
Placebo
n=10
Allergen
n=10
Increase of median
allergen tolerance
against baseline
factor of 10
factor of 10
factor of 1
factor of 10
p-value <0.05 <0.05 n.s. n.s.

Dr. Wolfgang Renner, CEO of Cytos Biotechnology commented: “With each study we gain a deeper
understanding of the activity of QbG10 in allergic diseases. If we look at the entire data set of the
80 allergic pa
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... NORFOLK, Va., Nov. 17, 2011 MedStar Health, Novant ... to reduce their supply expenses and improve operational performance. ... it has been named, represents more than $3 billion ... will work as a single entity on identified contracting ...
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... Piper Jaffray Health Care Conference in New York City ... You are invited to listen to the live ... or access it directly at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=HRC&item_id=4228792 .  A ...
Cached Medicine Technology:Three Large Not-for-profit Healthcare Systems Form New Supply Network 2
(Date:3/28/2015)... Centurion Service Group will be hosting a live ... at their Las Vegas warehouse, located at 4606 Andrews St. ... consists of equipment from hospitals and surgery centers from around ... , Buyers will find items of all types including ... one-stop-shop,” said Erik Tivin, CEO of Centurion. , Among the ...
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... 28, 2015 Healthpointe’s otolaryngologists, medical practitioners ... throat disorders, are now offering a wide variety ... which is characterized by the presence of phantom sounds ... people, tinnitus is a prevalent symptom that can arise ... is non-fatal, tinnitus can impede a person’s quality of ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... FL (PRWEB) March 27, 2015 Florida Hospital ... Storm as the team’s exclusive health care provider for the ... provider, Florida Hospital provides medical care and an athletic trainer ... Storm will kick off its season against the Cleveland Gladiators ... , “This partnership is extremely important to us as it ...
Breaking Medicine News(10 mins):Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3
... and then his legs become contorted into a complex yoga ... arch in the shape of the letter "C." , ,Sahakian ... His instructor does the work for him, performing a Thai ... moving, with ironically little work on the client's part. Some ...
... with endometriosis may have an increased risk of developing ... brain cancer. ,Endometriosis is a condition where tissue lining ... areas. The misplaced tissue may be found on the ... uterus.// Endometriosis is the most common cause of pelvic ...
... of obstructive sleep apnea, a sleep disorder that causes people ... to also promote bed-wetting in children, said Dr. Lee J. ... of Pennsylvania in Philadelphia. ,In a study of 160 ... sleep-disorders //clinic for suspected breathing problems at night, 66 children ...
... WHO said on Friday it expected to announce the removal of ... regions or countries where new cases of the deadly virus had ... period for the disease is 10 days, and twice that time ... local emergency situation over. ,The move, due to be announced ...
... of their brains than people who speak English, scientists ... insight into how the brain processes language. ,Unlike English ... understand the language, scientists at the Wellcome Trust research ... brain are used to interpret variations in sounds in ...
... That traffic ticket you just received could be preventing a ... say researchers who studied the impact of traffic convictions on ... ,Results show drivers run a significantly lower risk of getting ... conviction when compared to other months when no conviction took ...
Cached Medicine News:Health News:The 'lazy man's yoga" 2Health News:Sleep Apnea Linked to Bed-Wetting in Kids 2Health News:SARS-Free Taiwan to Mark End Phase of Global Fight 2
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... assay was originally developed for the World ... ovarian function. It has been widely used ... of natural family planning methods. Urine samples ... concentration measured by EIA (enzyme labelled immunoassay ...
... 10-8700 ACTIVE® Estrone Enzyme Immunosorbent Assay ... quantitative measurement of Estrone in serum. ... of enzyme immunoassay where there is ... an enzyme-labeled antigen for a fixed ...
Medicine Products: